Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to evaluate changes in key clinical outcome measures (eg, motor, respiratory, fatigue) in adult subjects with late-onset Pompe disease (LOPD) subjects receiving standard-of-care enzyme replacement therapy (ERT). Additionally, information gained may be used in the design and conduct of future studies in LOPD subjects.


Clinical Trial Description

The objective of this study is to evaluate the baseline characteristics and degree of change over time in clinical outcome measures commonly used to evaluate patients with LOPD. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03347253
Study type Observational
Source Amicus Therapeutics
Contact
Status Terminated
Phase
Start date December 8, 2017
Completion date November 30, 2018

See also
  Status Clinical Trial Phase
Terminated NCT02191917 - A Study of Respiratory Muscle Strength in Patients With Late-onset Pompe Disease (LOPD)
Recruiting NCT05431127 - High Dose Inspiratory Muscle Training in LOPD N/A
Terminated NCT01924845 - BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study) Phase 3